S&P 500
(-0.16%) 5 464.62 points
Dow Jones
(0.04%) 39 150 points
Nasdaq
(-0.18%) 17 689 points
Oil
(-0.86%) $80.59
Gas
(-0.80%) $2.72
Gold
(-1.45%) $2 334.70
Silver
(-4.03%) $29.58
Platinum
(1.22%) $996.30
USD/EUR
(0.09%) $0.935
USD/NOK
(0.17%) $10.56
USD/GBP
(0.08%) $0.790
USD/RUB
(2.04%) $89.05

Realtime updates for Lincoln Pharmaceuticals [LINCOLN.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated21 Jun 2024 @ 05:59

2.27% INR 617.20

Live Chart Being Loaded With Signals

Commentary (21 Jun 2024 @ 05:59):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics...

Stats
Today's Volume 30 518
Average Volume 54 266
Market Cap 12.36B
EPS INR9.28 ( Q4 | 2024-03-31 )
Next earnings date ( INR0 ) 2024-08-08
Last Dividend INR1.500 ( 2023-09-15 )
Next Dividend INR0 ( N/A )
P/E 13.25
(Sector) 0
(Industry) 0
ATR14 INR0.547 (0.09%)
AARTIDRUGS.NS -2.26%
ALKEM.NS -0.56%
ALPA.NS 3.97%
AMRUTANJAN.NS -1.03%
APLLTD.NS 2.82%
ASTRAZEN.NS -0.40%
AUROPHARMA.NS -0.17%
BAFNAPH.NS 0.00%
BALPHARMA.NS 2.02%
BIOFILCHEM.NS -0.81%
BLISSGVS.NS 0.82%
BROOKS.NS 0.69%
CADILAHC.NS 0.03%
DIVISLAB.NS 0.40%
DRREDDY.NS 0.68%
ERIS.NS 1.08%
FDC.NS 0.49%
GLENMARK.NS -0.86%
GLS.NS -1.18%
GRANULES.NS 3.89%
GUFICBIO.NS -1.02%
HESTERBIO.NS 20.00%
HIKAL.NS -0.11%
INDOCO.NS 0.57%
INDSWFTLAB.NS -0.66%
IOLCP.NS -1.16%
IPCALAB.NS 0.97%
JBCHEPHARM.NS -2.87%
JUBLPHARMA.NS -1.85%
KILITCH.NS -1.11%
KREBSBIO.NS -2.27%
LASA.NS 0.35%
LAURUSLABS.NS -0.66%
LINCOLN.NS 2.27%
LUPIN.NS 0.34%
MANGALAM.NS -1.36%
MEDICAMEQ.NS -1.24%
MEDICO.NS -1.19%
MOREPENLAB.NS -0.65%
NECLIFE.NS -0.60%
NOVARTIND.NS 0.26%
ORCHPHARMA.NS -1.71%
ORTINLAB.NS 1.28%
PAR.NS -0.94%
PDPL.NS 0.00%
PEL.NS -2.31%
PGHL.NS 0.91%
RPGLIFE.NS 0.72%
SAKAR.NS -0.78%
SEQUENT.NS -1.49%
SHILPAMED.NS 1.35%
SIGACHI.NS -0.30%
SOLARA.NS 0.97%
SPARC.NS -0.15%
STAR.NS -0.31%
SUNPHARMA.NS -0.25%
SUVEN.NS 0.10%
SUVENPHAR.NS -1.41%
SYNCOM.NS 1.19%
SYNCOMF.NS 1.52%
THEMISMED.NS -0.82%
TORNTPHARM.NS -0.94%
Correlation (AI algo v.1.1b): Undervalued: 0.01% INR617.24 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.11 (neutral)
Short: 0.51 (weak)
Signal:(52.542) Neutral

Lincoln Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lincoln Pharmaceuticals Correlation - Currency/Commodity

The country flag -0.70
( moderate negative )
The country flag -0.05
( neutral )
The country flag -0.93
( very strong negative )
The country flag -0.25
( neutral )
The country flag -0.19
( neutral )
The country flag 0.71
( moderate )

Lincoln Pharmaceuticals Financials

Annual 2023
Revenue: INR5.81B
Gross Profit: INR1.89B (32.50 %)
EPS: INR46.58
FY 2023
Revenue: INR5.81B
Gross Profit: INR1.89B (32.50 %)
EPS: INR46.58
FY 2022
Revenue: INR5.10B
Gross Profit: INR2.69B (52.70 %)
EPS: INR36.40
FY 2022
Revenue: INR4.68B
Gross Profit: INR2.48B (53.06 %)
EPS: INR34.63

Financial Reports:

No articles found.

Lincoln Pharmaceuticals Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR1.500
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR1.500
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Lincoln Pharmaceuticals Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.12 - Stable (2.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR1.000 2016-09-23
Last Dividend INR1.500 2023-09-15
Next Dividend INR0 N/A
Payout Date 2023-10-30
Next Payout Date N/A
# dividends 8 --
Total Paid Out INR11.20 --
Avg. Dividend % Per Year 0.32% --
Score 3.31 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.12
Div. Directional Score 8.68 --
Next Divdend (Est)
(2024-06-25)
INR1.526 Estimate 3.10 %
Dividend Stability
0.25 Very Poor
Dividend Score
3.31
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2016 INR1.000 0.41%
2017 INR1.200 0.64%
2018 INR1.500 0.63%
2019 INR1.500 0.66%
2020 INR1.500 0.73%
2021 INR1.500 0.62%
2022 INR1.500 0.41%
2023 INR1.500 0.42%
2024 INR0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
15 Sep 2023 INR1.500 30 Nov -0001 15 Sep 2023 30 Oct 2023
15 Sep 2022 INR1.500 30 Nov -0001 16 Sep 2022 30 Oct 2022
16 Sep 2021 INR1.500 30 Nov -0001 17 Sep 2021 30 Oct 2021
05 Mar 2020 INR1.500 24 Feb 2020 06 Mar 2020 28 Mar 2020
19 Sep 2019 INR1.500 30 May 2019 20 Sep 2019 30 Oct 2019
19 Sep 2018 INR1.500 30 May 2018 21 Sep 2018 29 Oct 2018
21 Sep 2017 INR1.200 30 May 2017 22 Sep 2017 29 Oct 2017
23 Sep 2016 INR1.000 30 May 2016 26 Sep 2016 30 Oct 2016

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
HINDZINC.NS Dividend Royal 2024-05-15 Semi-Annually 18 10.86% 7.69
CUPID.NS Dividend Royal 2023-09-18 Semi-Annually 9 23.43% 7.67
COALINDIA.NS Dividend Royal 2024-02-20 Semi-Annually 14 8.66% 7.17
ASTERDM.NS Ex Dividend King 2024-08-22 Semi-Annually 1 29.70% 6.69
HCLTECH.NS Dividend King 2024-05-07 Quarterly 23 3.22% 6.59
ONGC.NS Dividend King 2024-02-16 Semi-Annually 28 5.67% 6.48
IOC.NS Dividend King 2024-07-12 Semi-Annually 28 8.59% 6.40
NATIONALUM.NS Dividend King 2024-02-23 Semi-Annually 26 4.93% 6.39
FIEMIND.NS Dividend King 2024-07-24 Semi-Annually 18 5.81% 6.26
RITES.NS Dividend King 2024-02-09 Quarterly 7 4.62% 6.21

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1611.5006.7910.00[0 - 0.5]
returnOnAssetsTTM0.1331.2005.566.67[0 - 0.3]
returnOnEquityTTM0.1711.5009.2210.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM4.840.80010.008.00[1 - 3]
quickRatioTTM3.820.80010.008.00[0.8 - 2.5]
cashRatioTTM0.1501.500-0.278-0.418[0.2 - 2]
debtRatioTTM0.00152-1.5009.97-10.00[0 - 0.6]
interestCoverageTTM66.881.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM7.932.007.3610.00[0 - 30]
freeCashFlowPerShareTTM7.932.006.0410.00[0 - 20]
debtEquityRatioTTM0.00180-1.5009.99-10.00[0 - 2.5]
grossProfitMarginTTM0.4221.0006.296.29[0.2 - 0.8]
operatingProfitMarginTTM0.1691.0008.628.62[0.1 - 0.6]
cashFlowToDebtRatioTTM14.881.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.8290.8007.816.25[0.5 - 2]
Total Score12.24

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.401.0008.750[1 - 100]
returnOnEquityTTM0.1712.509.5010.00[0.1 - 1.5]
freeCashFlowPerShareTTM7.932.007.3610.00[0 - 30]
dividendYielPercentageTTM0.2401.5003.990[0 - 0.4]
operatingCashFlowPerShareTTM7.932.007.3610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.1731.5005.520[0.5 - 2]
operatingCashFlowSalesRatioTTM0.02731.000-1.8160[0.1 - 0.5]
Total Score5.12

Lincoln Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.7224681377411 seconds
Number of API calls: 3
Number of DB calls: 9